EU's IMI Plans Projects On 'Big Data' In Health Outcomes
This article was originally published in Scrip
Executive Summary
Having already launched programs this year on an Ebola vaccine and the adaptive pathways approach to drug development, the Innovative Medicines Initiative (IMI), a European public-private collaboration, is now preparing to launch a number of projects looking at how "big data" can be used to improve health outcomes.